Anti Suicide Drugs Market Outlook and Overview by PBIPosted by venkatakiran on November 7th, 2019 Anti-Suicide Drugs Market Size and Growth Rate:
“The Global Anti-Suicide Drugs Market was valued at US$ 3,514.3 Mn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to growing number of suicide rates across the world” Anti-Suicide Drugs Market Growth Drivers and Restraints: The global Anti-Suicide drugs market was valued at US$ 3,514.3 Mn in 2018 and growing at a CAGR of 4.2% over the forecast period owing to growing population with psychotic disorders, clinical depressive syndrome, and depression are the major driving factors for the growth of the market over the forecast years. Increasing suicidal rates across the globe, for instance, according to the WHO, more than 800K deaths are happening every year are suicide cases. The number of suicide cases are increasing owing to economic crisis with in the family and social negligence coupled with rapid adoption of new therapies for anti-suicides fuels the growth of the market. However, rising abuse of drugs, lack of effective therapies available for suicide cases are anticipated to restrain the growth of the market. Browse More Insights of the report @https://www.precisionbusinessinsights.com/market-reports/global-anti-suicide-drugs-market/
NMDA antagonists segment accounted for higher revenue share Based on drug class, global Anti-Suicide drugs market is segmented into Anti-depressants, Anti-anxiety drugs, Anti-psychotic drugs, NMDA Antagonists, and Antibiotic analogues. NMDA antagonists segment accounted for the largest market share in 2018 and is expected to grow with highest CAGR over the forecast period owing to launch of new products in the market and increasing number of studies for the approval of new drugs are expected to boost the growth of the market. Anti-psychotic drugs, anti-depressants are also expected to fuel in the future years with significant growth rate. North America holds leading position in Global Anti-Suicide Drugs Market
PBI’s global Anti-Suicide drugs market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to rising occurrence of suicidal cases, increase in healthcare spending and launch of various anti-suicidal drugs. As per, 2014 estimations of American Foundation for Suicide Prevention, the suicide rate in U.S was around 12.93 /1,000 people. Developing countries in APAC region are anticipated to show the significant growth throughout the forecast period owing to increasing awareness about the mental health, increasing visits of people to psychiatrists and psychologists, upsurge in the number of associations which are working on spreading the awareness, and increasing suicide incidences. According to the data estimation of WHO in 2012, India, Russia, Guyana, Republic of Korea, Sri Lanka, Japan, and Kazakhstan are the nations with high suicidal rates. Recent Developments in the Global Anti-Suicide Drugs Market
Key player’s profiles in the report are AstraZeneca plc (UK), Allergan plc, Eli Lilly and Company (UK), H. Lundbeck A/S (Denmark), GlaxoSmithKline plc (UK), Johnson & Johnson (U.S), Merck & Co., Inc. (U.S), Pfizer, Inc. (U.S) to name some few. Avail Sample of the report @https://www.precisionbusinessinsights.com/request-sample?product_id=17036 Detailed Segmentation of Anti-Suicide Drugs Market:
By Drug Class o Anti-depressants o Anti-anxiety drugs o Anti-psychotic drugs o NMDA Antagonists o Antibiotic analogues By Route of Administration o Oral o Parenteral
By Distribution Channel o Hospitals o Clinics o Online pharmacies o Retail pharmacies Geography
o North America o Europe o Asia-Pacific o Latin America o Middle East and Africa (MEA) About Us: Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights. Contact Us: Shreya Paul Senior Business Development Executive Email @ shreya@precisionbusinessinsights.com Call @ +1-866-598-1553 Precision Business Insights Like it? Share it! More by this author |